Literature DB >> 3026787

Measurement of 1,25-dihydroxyvitamin D3 receptor turnover by dense amino acid labeling: changes during receptor up-regulation by vitamin D metabolites.

E M Costa, D Feldman.   

Abstract

We have previously demonstrated that 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] receptors are up-regulated by exposure to 24,25-(OH)2D3 and other vitamin D metabolites in several mammalian cell cultures systems as well as in vivo in rats. The goal of the current study was to determine how changes in receptor turnover could give rise to increased receptor levels after treatment with 24,25-(OH)2D3, whether by an increased rate of synthesis or a decreased rate of degradation. Receptor turnover was studied by the dense amino acid shift technique in cultured pig kidney cells (LLC-PK1). In control cells, the half-life of the 1,25-(OH)2D3 receptor was estimated to be 4.3 +/- 0.4 h, with a degradation rate constant (kD) of 0.16 +/- 0.01 h-1. In parallel experiments, cells were treated with 24,25-(OH)2D3 for about 48 h to reach a new up-regulated steady state before the measurement of receptor turnover. In up-regulated cells, the receptor half-life was prolonged to 8.9 +/- 1.0 h and the kD was 0.07 +/- 0.01 h-1. Assuming a steady state, the values obtained for total receptor levels and the degradation rate allow calculation of the synthesis rate (kS) at equilibrium. Control cells synthesized receptors at the rate of 3.4 +/- 0.4 vs. up-regulated cells at 4.9 +/- 0.5 fmol mg protein-1 h-1. In conclusion, the data indicate that up-regulation of receptors after exposure of cells to vitamin D metabolites results predominantly from a prolongation of receptor half-life in addition to a relatively smaller increase in the rate of receptor synthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3026787     DOI: 10.1210/endo-120-3-1173

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  The mRNA expression of the human 1,25-dihydroxyvitamin D3 receptor and the c-myc protooncogene in cultured human keratinocytes.

Authors:  N M Hanafin; K S Persons; M F Holick
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

2.  Ethanol and vitamin D receptor in T cell apoptosis.

Authors:  Shabina Rehman; Nirupama Chandel; Divya Salhan; Partab Rai; Bipin Sharma; Tejinder Singh; Mohammad Husain; Ashwani Malhotra; Pravin C Singhal
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-06       Impact factor: 4.147

3.  Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.

Authors:  J Yao; P Kathpalia; D A Bushinsky; M J Favus
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.

Authors:  J Reichrath; J Kamradt; X H Zhu; X F Kong; W Tilgen; M F Holick
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

5.  Vitamin D controls T cell antigen receptor signaling and activation of human T cells.

Authors:  Marina Rode von Essen; Martin Kongsbak; Peter Schjerling; Klaus Olgaard; Niels Odum; Carsten Geisler
Journal:  Nat Immunol       Date:  2010-03-07       Impact factor: 25.606

6.  Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo.

Authors:  T Naveh-Many; R Marx; E Keshet; J W Pike; J Silver
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

7.  Evidence for in vivo upregulation of 1,25(OH)2 vitamin D3 receptor in human monocytes.

Authors:  J Merke; M Nawrot; U Hügel; A Szabo; E Ritz
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

8.  Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts.

Authors:  L A Crofts; M S Hancock; N A Morrison; J A Eisman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Conformational change and enhanced stabilization of the vitamin D receptor by the 1,25-dihydroxyvitamin D3 analog KH1060.

Authors:  G C van den Bemd; H A Pols; J C Birkenhäger; J P van Leeuwen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells?

Authors:  Martin Grimm; Dorothea Alexander; Adelheid Munz; Juergen Hoffmann; Siegmar Reinert
Journal:  Target Oncol       Date:  2013-01-15       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.